XAGE Longevity Health Holdings, Inc.

Fundamentals / CIK 0001842939 / USD
Other share classes on CIK 0001842939: XAGEW

Longevity Health Holdings, Inc. reported $1.69M in revenue and a net loss of $6.83M for the trailing twelve months ended June 30, 2026 (down 21.4% year over year), with a 59.0% gross margin and a -343.6% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open XAGE in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

5 fiscal years (2021 to 2025), reported in USD.

$3.52M$1.76M$0-$14.60MFY 2021 Net Income: -$329K2021FY 2022 Net Income: -$9.05M2022FY 2023 Revenue: $0FY 2023 Net Income: -$15.45M2023FY 2024 Revenue: $50KFY 2024 Net Income: -$10.37M2024FY 2025 Revenue: $1.91MFY 2025 Net Income: -$6.91M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $1.91M $50K $0 -- --
Cost of Revenue $818K $6.4K $0 -- --
Gross Profit $1.09M $44K $0 -- --
Research & Development $789K $1.05M $2.50M $2.20M --
Total Operating Expenses $8.20M $5.04M $5.94M $5.51M --
Operating Income -$7.11M -$5.00M -$5.94M -$5.51M -$467K
EBITDA -$7.03M -$4.92M -$5.85M -$5.41M --
Interest Expense $18K $29K $34K -- --
Income Before Tax -$6.87M -$10.75M -$16.21M -$9.05M -$329K
Income Tax Expense $36K -$97K $0 $0 $0
Net Income -$6.91M -$10.37M -$15.45M -$9.05M -$329K
Basic EPS -$4.83 -$14.56 -$43.84 -$164.26 --
Diluted EPS -$4.83 -$14.56 -$43.84 -$164.26 --
Basic Shares Outstanding 1.4M 712.1K 367.0K 58.5K --
Diluted Shares Outstanding 1.4M 712.1K 367.0K 58.5K --

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue $396K $392K $473K $426K $504K $510K $17K $21K
Cost of Revenue $160K $155K $205K $171K $201K $241K $1.2K $4.8K
Gross Profit $236K $237K $268K $254K $303K $270K $16K $16K
Research & Development $73K $55K $104K $228K $229K $197K $189K $332K
Selling, General & Admin $873K -- -- -- $1.91M -- -- --
Total Operating Expenses $960K $1.57M $2.54M $1.73M $2.16M $1.78M $1.02M $1.44M
Operating Income -$724K -$1.33M -$2.27M -$1.47M -$1.86M -$1.51M -$1.01M -$1.42M
EBITDA -$711K -$1.31M -$2.25M -$1.45M -$1.84M -$1.48M -$988K -$1.40M
Interest Expense -- $3.5K $5.6K $5.1K $2.6K $5.0K $7.5K $7.1K
Income Before Tax -$1.88M -$1.43M -$2.05M -$1.43M -$1.89M -$1.51M -$1.01M -$2.88M
Income Tax Expense $0 $0 $36K $0 $0 $0 -$97K $0
Net Income -$1.88M -$1.43M -$2.08M -$1.43M -$1.89M -$1.51M -$914K -$2.88M
Basic EPS -$0.76 -$0.75 -- -$0.83 -$1.56 -$1.52 -- -$4.13
Diluted EPS -- -$0.75 -- -$0.83 -$1.56 -$1.52 -- -$4.13
Basic Shares Outstanding 2.5M 1.9M -- 1.7M 1.2M 991.2K -- 696.8K
Diluted Shares Outstanding -- 1.9M -- 1.7M 1.2M 991.2K -- 696.8K

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $707K $157K $2.91M $128K $774K
Cash & Short-Term Investments $707K $157K $2.91M $128K $774K
Accounts Receivable, Net $36K $4.1K $0 $0 --
Inventory $963K $109K $0 $0 --
Other Current Assets -- -- $0 $28K --
Total Current Assets $1.95M $956K $62.90M $606K $973K
Property, Plant & Equipment, Net $102K $114K $193K $255K --
Goodwill -- -- -- $0 --
Intangible Assets $15K $20K $24K $29K --
Total Non-Current Assets $417K $518K $1.05M $1.14M $154.4M
Total Assets $2.37M $1.47M $63.95M $1.75M $155.4M
Accounts Payable $4.49M $4.06M $4.42M $2.14M --
Total Current Liabilities $7.92M $5.88M $38.50M $7.30M $330K
Total Non-Current Liabilities $318K $310K $698K $828K $5.41M
Total Liabilities $8.23M $6.19M $39.20M $8.12M $5.74M
Total Debt (incl. Leases) $310K $398K $848K $957K --
Common Stock $178 $70 $2.3K $897 --
Retained Earnings -$75.78M -$68.87M -$58.50M -$42.38M -$4.76M
Total Stockholders' Equity -$5.87M -$4.71M $24.75M -$37.79M -$29.58M
Total Equity -$5.87M -$4.71M $24.75M -$37.79M -$29.58M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Cash & Cash Equivalents $35K $313K $707K $1.11M $1.55M $770K $157K $1.14M
Cash & Short-Term Investments $35K $313K $707K $1.11M $1.55M $770K $157K $1.14M
Accounts Receivable, Net $20K $49K $36K $47K $54K $95K $4.1K --
Inventory $607K $735K $963K $1.01M $1.17M $1.38M $109K $98K
Total Current Assets $712K $1.26M $1.95M $2.84M $3.24M $2.79M $956K $1.88M
Property, Plant & Equipment, Net $76K $88K $102K $117K $118K $139K $114K $131K
Intangible Assets $13K $14K $15K $16K $17K $19K $20K $21K
Total Non-Current Assets $344K $380K $417K $455K $478K $544K $518K $557K
Total Assets $1.06M $1.64M $2.37M $3.30M $3.72M $3.34M $1.47M $2.44M
Accounts Payable $5.04M $5.05M $4.49M $4.17M $4.59M $4.60M $4.06M $4.21M
Total Current Liabilities $9.59M $8.35M $7.92M $6.84M $6.91M $6.60M $5.88M $6.17M
Total Non-Current Liabilities $162K $188K $318K $435K $543K $544K $310K $333K
Total Liabilities $9.75M $8.54M $8.23M $7.28M $7.46M $7.14M $6.19M $6.51M
Total Debt (incl. Leases) $261K $285K $310K $333K $355K $402K $398K $419K
Common Stock $247 $247 $178 $178 $148 $100 $70 $2.1K
Retained Earnings -$79.09M -$77.21M -$75.78M -$73.69M -$72.26M -$70.38M -$68.87M -$67.96M
Total Stockholders' Equity -$8.70M -$6.89M -$5.87M -$3.98M -$3.74M -$3.81M -$4.71M -$4.06M
Total Equity -$8.70M -$6.89M -$5.87M -$3.98M -$3.74M -$3.81M -$4.71M -$4.06M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$6.91M -$10.65M -$16.21M -$9.05M -$329K
Depreciation & Amortization $79K $83K $97K $94K --
Stock-Based Compensation $693K $827K $668K $636K $0
Change in Receivables $44K -$4.1K -- -- --
Change in Inventory $371K -$109K -- -- --
Change in Payables $127K -$359K -$450K $1.06M --
Operating Cash Flow -$3.33M -$3.89M -$8.35M -$3.43M -$451K
Capital Expenditure -$14K -- -$30K -$7.2K --
Free Cash Flow -$3.34M -- -$8.38M -$3.44M --
Investing Cash Flow -$164K -$749K -$30K -$7.2K --
Common Stock Issued $3.48M $2.69M -- -- --
Share Repurchases -- -- $0 -$2.3K --
Financing Cash Flow $4.04M $1.89M $11.16M $3.55M $155.7M
Net Change in Cash $550K -$2.76M $2.78M $116K $774K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Net Income -$1.88M -$1.43M -$2.08M -$1.43M -$1.89M -$1.51M -$914K -$2.88M
Depreciation & Amortization $13K $15K $16K $16K $22K $24K $18K $18K
Stock-Based Compensation $79K $146K $194K $190K $194K $115K $266K $186K
Change in Receivables $29K -$12K $10K $8.0K $40K -$14K -- --
Change in Inventory $89K $31K $36K $112K $207K $15K -- --
Change in Payables -$6.5K $551K $324K -$456K -$58K $317K -$156K $119K
Operating Cash Flow -$224K -$485K -$306K -$1.43M -$836K -$753K -$772K -$907K
Investing Cash Flow -- -- -$1 $776 -$15K -$150K $0 $0
Common Stock Issued $0 $190K $0 $86K $1.76M $1.64M -- --
Financing Cash Flow -$54K $92K -$96K $991K $1.63M $1.52M -$208K -$154K
Net Change in Cash -- -$393K -$402K -$442K $781K $613K -$980K -$1.06M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 57.2% 87.4% -- -- --
Operating Margin -371.6% -9933.8% -- -- --
Net Profit Margin -361.0% -20605.5% -- -- --
Return on Equity (ROE) -- -- -62.4% -- --
Return on Assets (ROA) -291.7% -703.4% -24.2% -517.6% -0.2%
Current Ratio 0.25x 0.16x 1.63x 0.08x 2.95x
Quick Ratio 0.12x 0.14x 1.63x 0.08x 2.35x
Debt to Equity -- -- 0.03x -- --
Revenue Growth (YoY) +3701.4% -- -- -- --
Gross Profit Growth (YoY) +2390.3% -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Gross Margin 59.0% 59.2% 57.2% 57.9% 57.5% 56.0% 87.4% --
Operating Margin -343.6% -386.2% -371.6% -401.0% -550.6% -914.1% -9933.8% --
Net Profit Margin -404.8% -380.7% -361.0% -393.6% -683.0% -1534.4% -20605.5% --
Return on Assets (ROA) -647.0% -415.9% -291.7% -173.9% -193.2% -257.8% -703.4% -257.9%
Current Ratio 0.07x 0.15x 0.25x 0.42x 0.47x 0.42x 0.16x 0.31x
Quick Ratio 0.01x 0.06x 0.12x 0.27x 0.30x 0.21x 0.14x 0.29x
Revenue Growth (YoY) -21.4% -23.2% +2606.0% +1975.5% +3987.8% -- -- --
Gross Profit Growth (YoY) -22.2% -12.2% +1547.7% +1523.0% +2416.3% -- -- --
Net Income Growth (YoY) -- -- -- -- -- -- -129.0% --
Source: SEC EDGAR CompanyFacts (CIK 0001842939) · from March 31, 2021 Data through June 30, 2026 · synced Nov 21, 2026, 05:15 UTC · Open in terminal